theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Allergy & Immunology

Hematologic Malignancies   

Questions discussed in this category


Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
6 Answers available

Does receiving IVIG confound the result of SPEP and/or UPEP?
2 Answers available

For which rituximab infusion reaction symptoms do you consider it safe to re-challenge in the office with adjusted rates and pre-medications?
1 Answer available

How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?
2 Answers available
206291759787798485


Papers discussed in this category


JAMA network open, 2018-11-02
Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

The journal of allergy and clinical immunology. In practice, 2017
Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review.

Journal of the Endocrine Society, 2022 Dec 02
Perioperative Evaluation and Management of Patients on Glucocorticoids.

Diagnostics (Basel, Switzerland), 2021 Apr 20
Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice.

Related Topics in Allergy & Immunology

  • Breast Cancer
  • Hematologic Malignancies
  • Radiation Oncology
  • Pediatric Hematology/Oncology
  • Medical Oncology
  • Bone Marrow Transplant
  • Biologic Therapy/Immunobiology
  • Supportive Care
  • General Internal Medicine
  • Rheumatology

Copyright © 2025 theMednet
All Rights Reserved.